Teva Phanaksri
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Teva Phanaksri has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Anthicha Kunjantarachot
Chulabhorn International College of Medicine, Thammasat University, Pathum Thani, Thailand
1 shared publication - Junya Pattaraarchachai
Chulabhorn International College of Medicine, Thammasat University, Khlong Luang district, Thailand
1 shared publication Juthakorn Poothong
1 shared publicationJutharat Kulsantiwong
Faculty of Science, Udon Thani Rajabhat University, Udon Thani, Thailand
1 shared publication- Kritiya Butthongkomvong
Medical Oncology Unit, Udonthani Cancer Hospital, Ministry of Public Health, Udon Thani, Thailand
1 shared publication - Linrui Xia
Clinical Medicine School, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, People’s Republic of China
1 shared publication
Latest Publications
- 5 October 2026
- Published by Elsevier in Protein Expression and Purification
- Vol. 244
N-glycosylation is essential for the expression of recombinant human interleukin-40 in Komagataella phaffii
- 5 October 2026
- Published by Elsevier in Protein Expression and Purification
- Vol. 244
N-glycosylation is essential for the expression of recombinant human interleukin-40 in Komagataella phaffii
- Open Access
- 1 September 2026
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 19, 1-19
Macrophage Immunometabolism in Epicardial Adipose Tissue and Obesity-Related Atrial Fibrillation
Obesity is a crucial risk factor for atrial fibrillation (AF). The underlying mechanism is partly related to increased epicardial adipose tissue (EAT). EAT directly contacts the adjacent cardiac myocardium where immune and metabolic activities interact. Obesity induces inflammatory and metabolic signals within EAT, which directly influence atrial structure and electrical remodeling. However, the specific immunometabolic mechanisms linking EAT macrophages to atrial arrhythmogenesis remain unclear. We highlight evidence that nutrient excess, hypoxia, oxidative stress, and adipocyte-derived inflammatory signals reprogram glucose, lipid, and amino acid metabolism in EAT macrophages, promoting persistent pro-inflammatory and profibrotic states. Metabolic pathways involving mechanistic target of rapamycin (mTOR)–hypoxia-inducible factor-1α (HIF-1α) signaling, fatty acid and ceramide metabolism, the NOD-, LRR- and pyrin domain-containing protein 3 (NLRP3) inflammasome, and metabolic–epigenetic interactions may sustain macrophage activation and amplify local inflammation. These metabolically reprogrammed macrophages subsequently promote atrial fibrosis, electrical heterogeneity, and autonomic dysfunction, while systemic inflammation, insulin resistance, and neurohumoral activation further reinforce the EAT–atrial pathological circuit. Emerging evidence also suggests that EAT characteristics may improve AF risk stratification and that weight loss and metabolic interventions can attenuate EAT inflammation. More importantly, targeting macrophage immunometabolism may offer a mechanistically distinct approach to interrupt the link between obesity and atrial remodeling rather than treating AF solely after its substrate has developed. Collectively, targeting EAT immunometabolism may shift obesity-related AF management from treating an established arrhythmia toward identifying and modifying the metabolic-inflammatory substrate that promotes its development and recurrence, potentially complementing conventional rhythm-control and ablation strategies. Future studies should establish causal relationships and identify clinically actionable metabolic targets for EAT macrophage-directed therapy.
- 1 September 2026
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 19, 1-19
Open AccessMacrophage Immunometabolism in Epicardial Adipose Tissue and Obesity-Related Atrial Fibrillation
Obesity is a crucial risk factor for atrial fibrillation (AF). The underlying mechanism is partly related to increased epicardial adipose tissue (EAT). EAT directly contacts the adjacent cardiac myocardium where immune and metabolic activities interact. Obesity induces inflammatory and metabolic signals within EAT, which directly influence atrial structure and electrical remodeling. However, the specific immunometabolic mechanisms linking EAT macrophages to atrial arrhythmogenesis remain unclear. We highlight evidence that nutrient excess, hypoxia, oxidative stress, and adipocyte-derived inflammatory signals reprogram glucose, lipid, and amino acid metabolism in EAT macrophages, promoting persistent pro-inflammatory and profibrotic states. Metabolic pathways involving mechanistic target of rapamycin (mTOR)–hypoxia-inducible factor-1α (HIF-1α) signaling, fatty acid and ceramide metabolism, the NOD-, LRR- and pyrin domain-containing protein 3 (NLRP3) inflammasome, and metabolic–epigenetic interactions may sustain macrophage activation and amplify local inflammation. These metabolically reprogrammed macrophages subsequently promote atrial fibrosis, electrical heterogeneity, and autonomic dysfunction, while systemic inflammation, insulin resistance, and neurohumoral activation further reinforce the EAT–atrial pathological circuit. Emerging evidence also suggests that EAT characteristics may improve AF risk stratification and that weight loss and metabolic interventions can attenuate EAT inflammation. More importantly, targeting macrophage immunometabolism may offer a mechanistically distinct approach to interrupt the link between obesity and atrial remodeling rather than treating AF solely after its substrate has developed. Collectively, targeting EAT immunometabolism may shift obesity-related AF management from treating an established arrhythmia toward identifying and modifying the metabolic-inflammatory substrate that promotes its development and recurrence, potentially complementing conventional rhythm-control and ablation strategies. Future studies should establish causal relationships and identify clinically actionable metabolic targets for EAT macrophage-directed therapy.
- Open Access
- 28 November 2023
- Published by Korean Society for Parasitology in Parasites, Hosts and Diseases
- Vol. 61 (4) , 463-470
Update on the risk factors for opisthorchiasis and cholangiocarcinoma in Thailand
This study aimed to identify the recent risk factors for Opisthorchis viverrini infection and cholangiocarcinoma (CCA) to improve disease prevention. The participants were divided into the following 3 groups based on their health status: healthy control (nonOV and nonCCA), those with O. viverrini infection (OV), and those with CCA. A questionnaire was used to explore their lifestyle and behaviors. Multivariate logistic regression and backward elimination were used to identify the significant risk factors. The results showed that the significant risk factors for both O. viverrini infection and CCA were age>50 years (odd ratio (OR)=8.44, p50 years old, should be carefully monitored to prevent CCA.
- 28 November 2023
- Published by Korean Society for Parasitology in Parasites, Hosts and Diseases
- Vol. 61 (4) , 463-470
Open AccessUpdate on the risk factors for opisthorchiasis and cholangiocarcinoma in Thailand
This study aimed to identify the recent risk factors for Opisthorchis viverrini infection and cholangiocarcinoma (CCA) to improve disease prevention. The participants were divided into the following 3 groups based on their health status: healthy control (nonOV and nonCCA), those with O. viverrini infection (OV), and those with CCA. A questionnaire was used to explore their lifestyle and behaviors. Multivariate logistic regression and backward elimination were used to identify the significant risk factors. The results showed that the significant risk factors for both O. viverrini infection and CCA were age>50 years (odd ratio (OR)=8.44, p50 years old, should be carefully monitored to prevent CCA.